Molecular imaging approaches in the diagnosis of breast cancer: A systematic review and meta-analysis

  • سال انتشار: 1399
  • محل انتشار: مجله پزشکی هسته ای ایران، دوره: 28، شماره: 1
  • کد COI اختصاصی: JR_IRJNM-28-1_001
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 539
دانلود فایل این مقاله

نویسندگان

Getu Ferenji Tadesse

Department of Medical Physics and Biomedical Engineering, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran|International Campus, Department of Medical Physics and Biomedical Engineering, School of Medicine, Tehran University

Parham Geramifar

Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran

Pardis Ghafarian

Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran|PET/CT and Cyclotron Center, Masih Daneshvari Hospital, Shahid Beheshti

Eshetu Ejeta Cheka

Department of Public Health, College of Medical and Health Sciences, Ambo University, Ambo, Ethiopia

چکیده

Introduction:The accuracy of positron emission tomography with computed tomography (PET/CT), positron emission mammography (PEM), and breast specific-gamma imaging (BSGI) in diagnosing breast cancer has never been systematically assessed, the present systematic review was aimed to address this issue.  Methods:PubMed, Scopus and EMBASE were searched for studies dealt with the detection of breast cancer by PET/CT, PEM or BSGI. Histopathologic examination and/or at least six months imaging follow-up were used as a golden reference. To calculate diagnostic test parameters: sensitivity, specificity, summary receiver operating characteristic curves (SROC) and to test for heterogeneity, true positive (TP), true negative (TN), false positive (FP) and false negative (FN) were extracted. Results: Thirty one studies were included in the analysis. On per-patient basis, the pooled sensitivities after corrected for threshold effect for 18F-FDG PET/CT, PEM, and 99mTc-MIBI BSGI were 0.89 (95% CI: 0.78- 0.95), 0.73 (95% CI: 0.41 - 0.92), and 0.80 (95% CI: 0.72 - 0.86) respectively. The pooled specificities for detection of breast cancer using FDG PET/CT, PEM, and 99mTc-MIBI BSGI were 0.93 (95 % CI, 0.86 - 0.96), 0.91 (95 % CI, 0.77- 96), and 0.78 (95 % CI, 0.64 - 0.88), respectively. AUC of FDG PET/CT, PEM, and BSGI were 0.9549, 0.8852 and 0.8573, respectively. Conclusion: This meta-analysis indicated that PET/CT showed better diagnostic accuracy than PEM, and BSGI on per-patient basis. On per-lesion analysis, PEM with the highest AUC, DOR and Q* was better than PET/CT, and BSGI for detecting breast cancer.

کلیدواژه ها

Breast cancer, PET/CT, Positron emission mammography, Breast specific-gamma imaging, meta-analysis

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.